Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance. (Q41173046)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 March 2015
edit
Language Label Description Also known as
English
Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance.
scientific article published on 20 March 2015

    Statements

    title
    Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    25802191
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25802191%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 March 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q41173046&oldid=1538989957"